Treatment for Syndromes of Dementia and Movement Disorders Market: Overview
A rise in the incidence of various neurodegenerative diseases has greatly impacted the market for the treatment for syndromes of dementia and movement disorders. According to the World Health Organization, over 47 million people around the globe were living with dementia in 2015. This is projected to increase to over 75 million in another 15 years. Owing to the under-recognition of this group of diseases in the past, the market for the same holds a promising future.
The global market for treatment for syndromes of dementia and movement disorders can be bifurcated into technological treatment and drug-based treatment. Neurodegenerative diseases such as Lewy body dementia, Huntington’s disease, Alzheimer’s disease, Pick’s disease, and Parkinson’s disease can be controlled or treated with the help of therapeutic drugs and technological options such as tau tangling inhibitors, monoclonal antibodies, immunization strategies, and biomarkers.
The report offers a granular view of the treatment for syndromes of dementia and movement disorders market, taking into consideration the prominent forces acting in its favor and those creating roadblocks. A detailed evaluation of the regional and disease-type segments has been included in the study in order to give readers a clear and complete understanding of the market dynamics.
Treatment for Syndromes of Dementia and Movement Disorders Market: Trends and Opportunities
The market for treatment for syndromes of dementia and movement disorders is driven by a rapidly expanding geriatric population highly susceptible to various neurodegenerative diseases. According to HelpAge International, currently nearly 1 in 10 people are over the age of 60, which is likely to rise to 1 in 5 people by 2050. Moreover, by 2050, the number of people above the age of 60 will exceed that of children below the age of 14.
Another factor slated to positively impact the market are frequent collaborations between pharmaceutical companies, drug and device manufacturing firms, research organizations, and medical institutes. These alliances have resulted in aggressive R&D efforts aimed at the discovery of effective treatment options for syndromes of dementia and movement disorders.
The market is, nevertheless, affected by several challenges that threaten to impede its growth over the coming years. A key restraining factor is limited knowledge regarding brain mechanisms and the different neurodegenerative diseases. In addition to this, the absence of comprehensive therapeutic and management solutions for neurological disorders, drug failures in late-stage clinical trials, rigid regulatory requirements, and lengthy approval time for drugs and devices act as deterrents to the growth of the market for the treatment for syndromes of dementia and movement disorders.
Treatment for Syndromes of Dementia and Movement Disorders Market: Regional Outlook
Geographically, the market for the treatment for syndromes of dementia and movement disorders comprises Asia Pacific, North America, Europe, and Rest of the World. North America has accounted for a significant share in the overall market, driven primarily by the high incidence rate of neurodegenerative disorders, also resulting in a greater number of people living with restricted mobility. With a significantly aging American population, the number of people afflicted by various neurological diseases has increased. The National Institute of Neurological Disorders and Stroke finds that an estimated 50 million people in the U.S. are affected by a neurologic disorder each year. The market for the treatment for syndromes of dementia and movement disorders in Europe is also a strong contender in the overall scenario and is fueled by similar factors.
Asia Pacific is anticipated to register healthy growth over the course of the forecast period with an increasing number of awareness programs initiated by public as well as private healthcare institutions. A massive population base, including geriatrics, and expanding healthcare insurance coverage are also responsible for the projected growth of the Asia Pacific treatment for syndromes of dementia and movement disorders market.
Companies mentioned in the research report
Hoffmann-La Roche, Pfizer, AstraZeneca GmbH, Novartis AG, Merck & Co., Sanofi S.A., and Valeant Pharmaceutical International some of the leading players competing in the global market for the treatment for syndromes of dementia and movement disorders. Companies such as FORUM Pharmaceuticals, Axovant Sciences, and Biotie have, in the past, dedicated resources toward the research and development of treatment methods for key neurodegenerative disorders. Strong product pipeline has enabled many of these pharma companies to gain a strong foothold in the treatment for syndromes of dementia and movement disorders market. Other growth strategies that have proven to be effective in this market include collaborations, investments, and clinical trials.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?